News | June 18, 2008

Hand-Held POCI Camera Localizes Breast Cancer

June 19, 2008 – At the Society of Nuclear Medicine’s 55th Annual Meeting held in New Orleans, French researchers presented a handheld perioperative compact imager (POCI), a gamma camera used to perform lymphoscintigraphy for sentinel lymph node (SLN) localization in breast cancer.

Used for the surgical treatment of breast cancer the mini camera, which is sensitive to tumor tissue, guides the work of a surgeon. The POCI imaging device is currently being assessed in the context of a "sentinel lymph node" protocol in breast cancers. In practice, the cancer is detected by injecting a radioactive solution around the tumor. Lymphoscintigraphy can then count the lymph nodes and situate them precisely. Finally, a biopsy is usually performed in the operating room using the radioactive counter probe, which allows the surgeon to check the position of the "sentinel lymph node" prior to making an incision, in order to identify it in the surgical wound and then, after ablation, to confirm the absence of any residual radioactivity.

Arising from an initial collaboration between physicists at IN2P3-CNRS, physicians at Hôpital Tenon in Paris and methodologists from Paris Public Hospitals (AP-HP), this gamma camera is currently being assessed in the operating room on 200 women with breast cancer. This study, which has already generated some more than encouraging results, shows the value of peroperative imaging techniques.

For more information: and

Related Content

Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
News | Computed Tomography (CT) | May 21, 2018
The Istituto Oncologico Veneto (IOV) in Padua, Italy, has acquired MILabs’ latest-generation Versatile Emission...
The Chalk River nuclear reactor license has been renewed, but will be decommissioned by 2028.

The Chalk River nuclear isotope reactor license has been renewed, but will be decommissioned by 2028. The reactor supplies about 50 percent of the world's supply of Tc99m.

Feature | Nuclear Imaging | April 02, 2018 | Dave Fornell
April 2, 2018 – The Canadian Nuclear Safety Commission (CNSC) announced March 29 that it renewed Canadian Nuclear Lab
A Tc99m SPECT cardiac exam showing myocardial perfusion in the heart.

Technetium-99m is primarily used for the detection of cancer and to assess perfusion defects in the heart caused by heart attacks or other conditions.

Feature | Radiopharmaceuticals and Tracers | February 08, 2018 | Dave Fornell
February 8, 2018 — The U.S.
Philips Launches CardioMD IV Cardiac SPECT Solution at ASNC 2017
Technology | SPECT Imaging | September 15, 2017
September 15, 2017 — Philips highlighted its newest solution for...
Videos | Nuclear Imaging | August 24, 2017
Prem Soman, M.D., director of nuclear cardiology at the Heart and Vascular Institute, University of Pittsburgh, and p
Videos | Nuclear Imaging | August 24, 2017
Randy Thompson, M.D., attending cardiologist, St.
Overlay Init